Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Perrigo
Perrigo
Activities:
Ingredients
Pharmaceutical
Dietary supplements
Active Nutrition
Food
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Catalent client gets FDA approval for generic bronchodilator
Approval has marked the first generic metered-dose inhaler to be approved by the FDA in over twenty years and will now be scaled-up
Media
Hikma enters into licensing partnership with Perrigo in MENA
The partnership will provide significant collaboration opportunity
Finance
Mylan fails in US$26bn hostile takeover bid for Perrigo
Not enough shareholders supported the deal
Analysis
Operational cost savings for Perrigo UK
SP-4C weight checkers replace a manual sampling system
Finance
Perrigo to acquire OTC brands from GSK
In the areas of nicotine replacement therapy, cold and flu, and cold sore management
Drug Delivery
Perrigo acquires Patheon's Mexican operations for US$34m
Strengthening its capabilities with the addition of softgel manufacturing technology
Finance
Perrigo Board unanimously rejects unsolicited US$29bn bid from Mylan
Says it substantially undervalues the company and ignores key factors
Subscribe now